Anti-cancer Composition Using Green Propolis, Wheatgrass, and Mulberry Extracts

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current cancer treatment strategies, including anti-cancer drugs and photodynamic therapy, face limitations such as individual differences in patients, severe side effects, and multi-drug resistance, which hinder effective inhibition of cancer cell growth.

Innovation Solution

An anti-cancer composition comprising ethanol extracts of green propolis, wheatgrass, and mulberry leaves, administered alone or in combination with photodynamic therapy, to inhibit cancer cell growth.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If anti-cancer drugs or photodynamic therapy are used to treat cancer, then cancer cell growth can be inhibited, but severe side effects and multi-drug resistance occur

Engineering Contradiction:
Improvecancer cell growth inhibitionVSAvoidside effects and drug resistance
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent combines green propolis extract with wheatgrass extract and mulberry leaf extract to create a composite anti-cancer formulation. This composite approach leverages the synergistic effects of multiple natural compounds (flavonoids, phenolic acids, chlorophyllin, etc.) to inhibit cancer cell growth while reducing the harmful effects associated with conventional single-agent therapies.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent utilizes naturally derived, readily available plant materials (green propolis, wheatgrass, mulberry leaves) that can be extracted and used as disposable therapeutic agents. These natural extracts provide anti-cancer effects without the persistence and accumulation issues of synthetic drugs, reducing long-term side effects and resistance development.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Reliability

If conventional cancer treatment strategies are applied, then some therapeutic effect is achieved, but individual differences in patients limit the desired cure rate

Engineering Contradiction:
Improvetherapeutic effectVSAvoidpatient individual differences
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent employs a multi-component extract formulation that targets multiple cellular pathways simultaneously (apoptosis induction, cell cycle arrest, anti-oxidative stress). This multi-functional approach increases adaptability to different patient profiles and cancer types, overcoming the limitation of individualized response to single-agent therapies.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If green propolis extract is used alone for anti-cancer therapy, then some inhibition effect is observed, but enhanced efficacy is achieved when combined with photodynamic therapy

Engineering Contradiction:
Improvecancer cell growth inhibitionVSAvoidtreatment combination
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent merges green propolis extract therapy with photodynamic therapy (PDT) to create a combined treatment modality. The green propolis components (particularly chlorophyllin and phenolic compounds) act as photosensitizers that enhance PDT efficacy, while simultaneously providing chemopreventive effects. This combination approach achieves synergistic anti-cancer effects that exceed the sum of individual therapies.

Inventive Principle:
Principle #5Merging (Combining)

Data Source

PatentUS20240009258A1Anti-cancer composition and use thereof
Publication Date: 2024.01.11 DR OXFORD BIOTECH FACTORY CO LTD
  • US20240009258A1 patent drawing
  • US20240009258A1 patent drawing
  • US20240009258A1 patent drawing

AI summary

Disclosed herein is an anti-cancer composition that includes an ethanol extract of green propolis, an ethanol extract of wheatgrass, and an ethanol extract of mulberry leaves. Also disclosed herein is use of the anti-cancer composition for inhibiting the growth of cancer cells.